TFG Advisers’s Boston Scientific BSX Stock Holding History

TFG Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200	Closed	-$9K	–	187
2019 Q4	$9K	Buy	+200	New	+$8.37K	0.01%	407

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

TFG Advisers's BSX Position: Q1 2020 in Review

TFG Advisers sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 200 shares — an estimated $9K sold.

TFG Advisers first reported a position in BSX in Q4 2019 and held it in 1 quarter. The position peaked at $9K in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

TFG Advisers reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
TFG Advisers sold 200 Boston Scientific shares in Q1 2020, an estimated $9K.
TFG Advisers first reported a position in Boston Scientific in Q4 2019 and held it in 1 quarter.
TFG Advisers's Boston Scientific position peaked at $9K in Q4 2019.
800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on TFG Advisers's 13F filing for Q1 2020, filed 24 Apr 2020.